Announcement on Convening 2023 Annual Performance Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Convening 2023 Annual Performance Meeting
Filed with SSE ·
Announcement on Convening 2023 Annual Performance Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Earlier from BeOne Medicines
- Announcement on Equity Registration Date of 2024 Annual General Meeting
- Announcement on Appointing Member of Advisory Committee on Commercial and Medical Affairs of Board of Directors
- Announcement on Progress in Joint Investment with Related Party and Related Transaction
- Announcement on 2023 Annual Preliminary Earnings Estimate
- Announcement on Signing Consulting Agreement and Related Transaction
Later from BeOne Medicines
- Announcement on Voluntary Disclosure of European Commission's Approval of Baize'an (Tislelizumab Injection) for First-line and Second-line Treatment of Three Non-small Cell Lung Cancer Indications
- 2023 Annual Report
- Notice on Convening 2024 Annual General Meeting
- Announcement on Key Financial Data of 1st Quarter of 2024
- Announcement on Change of Senior Executive
Follow BeOne Medicines into a list and get an email when it puts out news.
Follow BeOne Medicines